Global Intravenous Immunoglobulins Market Research Report 2025(Status and Outlook)
Description
Report Overview
The market for Intravenous Immunoglobulins (IVIG) is a critical segment within the global biopharmaceutical industry, driven by the increasing prevalence of immunodeficiency disorders, autoimmune diseases, and chronic inflammatory conditions. IVIG, derived from pooled human plasma, contains antibodies that help modulate immune responses, making it a vital therapy for patients with primary and secondary immunodeficiencies, neurological disorders like Guillain-Barré syndrome, and autoimmune conditions such as ITP and CIDP. The market is characterized by high demand due to limited treatment alternatives, coupled with rising awareness and diagnosis rates of immune-related disorders. However, supply constraints, stringent regulatory requirements, and high production costs pose challenges. Key players focus on expanding production capacities, improving purification technologies, and developing subcutaneous alternatives to meet growing demand. Geographically, North America dominates due to robust healthcare infrastructure and reimbursement policies, while Asia-Pacific shows rapid growth driven by increasing healthcare expenditure and improving access to advanced therapies. The market is further influenced by patent expirations, biosimilar competition, and strategic collaborations among plasma collection centers and manufacturers to ensure stable supply chains.
The global Intravenous Immunoglobulins market size was estimated at USD 11594.19 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.96% during the forecast period.
This report provides a deep insight into the global Intravenous Immunoglobulins market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Intravenous Immunoglobulins Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Intravenous Immunoglobulins market in any manner.
Global Intravenous Immunoglobulins Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL Behring
Grifols
Octapharma
Takeda
ADMA Biologics
Bayer
Bharat Serum and Vaccines
Biotest
China Biologic Products
Hualan Biological Engineering
Kedrion Biopharma
LFB Group
Sanquin
Market Segmentation (by Type)
IgG
IgA
IgM
IgE
IgD
Market Segmentation (by Application)
Primary Immunodeficiency
Idiopathic Thrombocytopenic Purpura
Chronic Inflammatory Demyelinating Polyneuropathy
Kawasaki Disease
Guillain-Barre Syndrome
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Intravenous Immunoglobulins Market
Overview of the regional outlook of the Intravenous Immunoglobulins Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Intravenous Immunoglobulins Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Intravenous Immunoglobulins, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The market for Intravenous Immunoglobulins (IVIG) is a critical segment within the global biopharmaceutical industry, driven by the increasing prevalence of immunodeficiency disorders, autoimmune diseases, and chronic inflammatory conditions. IVIG, derived from pooled human plasma, contains antibodies that help modulate immune responses, making it a vital therapy for patients with primary and secondary immunodeficiencies, neurological disorders like Guillain-Barré syndrome, and autoimmune conditions such as ITP and CIDP. The market is characterized by high demand due to limited treatment alternatives, coupled with rising awareness and diagnosis rates of immune-related disorders. However, supply constraints, stringent regulatory requirements, and high production costs pose challenges. Key players focus on expanding production capacities, improving purification technologies, and developing subcutaneous alternatives to meet growing demand. Geographically, North America dominates due to robust healthcare infrastructure and reimbursement policies, while Asia-Pacific shows rapid growth driven by increasing healthcare expenditure and improving access to advanced therapies. The market is further influenced by patent expirations, biosimilar competition, and strategic collaborations among plasma collection centers and manufacturers to ensure stable supply chains.
The global Intravenous Immunoglobulins market size was estimated at USD 11594.19 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.96% during the forecast period.
This report provides a deep insight into the global Intravenous Immunoglobulins market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Intravenous Immunoglobulins Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Intravenous Immunoglobulins market in any manner.
Global Intravenous Immunoglobulins Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL Behring
Grifols
Octapharma
Takeda
ADMA Biologics
Bayer
Bharat Serum and Vaccines
Biotest
China Biologic Products
Hualan Biological Engineering
Kedrion Biopharma
LFB Group
Sanquin
Market Segmentation (by Type)
IgG
IgA
IgM
IgE
IgD
Market Segmentation (by Application)
Primary Immunodeficiency
Idiopathic Thrombocytopenic Purpura
Chronic Inflammatory Demyelinating Polyneuropathy
Kawasaki Disease
Guillain-Barre Syndrome
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Intravenous Immunoglobulins Market
Overview of the regional outlook of the Intravenous Immunoglobulins Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Intravenous Immunoglobulins Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Intravenous Immunoglobulins, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
153 Pages
- 1 Research Methodology And Statistical Scope
- 1.1 Market Definition And Statistical Scope Of Intravenous Immunoglobulins
- 1.2 Key Market Segments
- 1.2.1 Intravenous Immunoglobulins Segment By Type
- 1.2.2 Intravenous Immunoglobulins Segment By Application
- 1.3 Methodology & Sources Of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown And Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Intravenous Immunoglobulins Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Intravenous Immunoglobulins Market Size (M Usd) Estimates And Forecasts (2020-2033)
- 2.1.2 Global Intravenous Immunoglobulins Sales Estimates And Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size By Region
- 3 Intravenous Immunoglobulins Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Intravenous Immunoglobulins Product Life Cycle
- 3.3 Global Intravenous Immunoglobulins Sales By Manufacturers (2020-2025)
- 3.4 Global Intravenous Immunoglobulins Revenue Market Share By Manufacturers (2020-2025)
- 3.5 Intravenous Immunoglobulins Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.6 Global Intravenous Immunoglobulins Average Price By Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, And Product Types
- 3.8 Intravenous Immunoglobulins Market Competitive Situation And Trends
- 3.8.1 Intravenous Immunoglobulins Market Concentration Rate
- 3.8.2 Global 5 And 10 Largest Intravenous Immunoglobulins Players Market Share By Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Intravenous Immunoglobulins Industry Chain Analysis
- 4.1 Intravenous Immunoglobulins Industry Chain Analysis
- 4.2 Market Overview Of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development And Dynamics Of Intravenous Immunoglobulins Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 Pest Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Intravenous Immunoglobulins Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions And Their Impacts To Intravenous Immunoglobulins Market
- 5.7 Esg Ratings Of Leading Companies
- 6 Intravenous Immunoglobulins Market Segmentation By Type
- 6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
- 6.2 Global Intravenous Immunoglobulins Sales Market Share By Type (2020-2025)
- 6.3 Global Intravenous Immunoglobulins Market Size Market Share By Type (2020-2025)
- 6.4 Global Intravenous Immunoglobulins Price By Type (2020-2025)
- 7 Intravenous Immunoglobulins Market Segmentation By Application
- 7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
- 7.2 Global Intravenous Immunoglobulins Market Sales By Application (2020-2025)
- 7.3 Global Intravenous Immunoglobulins Market Size (M Usd) By Application (2020-2025)
- 7.4 Global Intravenous Immunoglobulins Sales Growth Rate By Application (2020-2025)
- 8 Intravenous Immunoglobulins Market Sales By Region
- 8.1 Global Intravenous Immunoglobulins Sales By Region
- 8.1.1 Global Intravenous Immunoglobulins Sales By Region
- 8.1.2 Global Intravenous Immunoglobulins Sales Market Share By Region
- 8.2 Global Intravenous Immunoglobulins Market Size By Region
- 8.2.1 Global Intravenous Immunoglobulins Market Size By Region
- 8.2.2 Global Intravenous Immunoglobulins Market Size Market Share By Region
- 8.3 North America
- 8.3.1 North America Intravenous Immunoglobulins Sales By Country
- 8.3.2 North America Intravenous Immunoglobulins Market Size By Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Intravenous Immunoglobulins Sales By Country
- 8.4.2 Europe Intravenous Immunoglobulins Market Size By Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Intravenous Immunoglobulins Sales By Region
- 8.5.2 Asia Pacific Intravenous Immunoglobulins Market Size By Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Intravenous Immunoglobulins Sales By Country
- 8.6.2 South America Intravenous Immunoglobulins Market Size By Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East And Africa
- 8.7.1 Middle East And Africa Intravenous Immunoglobulins Sales By Region
- 8.7.2 Middle East And Africa Intravenous Immunoglobulins Market Size By Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 Uae Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Intravenous Immunoglobulins Market Production By Region
- 9.1 Global Production Of Intravenous Immunoglobulins By Region(2020-2025)
- 9.2 Global Intravenous Immunoglobulins Revenue Market Share By Region (2020-2025)
- 9.3 Global Intravenous Immunoglobulins Production, Revenue, Price And Gross Margin (2020-2025)
- 9.4 North America Intravenous Immunoglobulins Production
- 9.4.1 North America Intravenous Immunoglobulins Production Growth Rate (2020-2025)
- 9.4.2 North America Intravenous Immunoglobulins Production, Revenue, Price And Gross Margin (2020-2025)
- 9.5 Europe Intravenous Immunoglobulins Production
- 9.5.1 Europe Intravenous Immunoglobulins Production Growth Rate (2020-2025)
- 9.5.2 Europe Intravenous Immunoglobulins Production, Revenue, Price And Gross Margin (2020-2025)
- 9.6 Japan Intravenous Immunoglobulins Production (2020-2025)
- 9.6.1 Japan Intravenous Immunoglobulins Production Growth Rate (2020-2025)
- 9.6.2 Japan Intravenous Immunoglobulins Production, Revenue, Price And Gross Margin (2020-2025)
- 9.7 China Intravenous Immunoglobulins Production (2020-2025)
- 9.7.1 China Intravenous Immunoglobulins Production Growth Rate (2020-2025)
- 9.7.2 China Intravenous Immunoglobulins Production, Revenue, Price And Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Csl Behring
- 10.1.1 Csl Behring Basic Information
- 10.1.2 Csl Behring Intravenous Immunoglobulins Product Overview
- 10.1.3 Csl Behring Intravenous Immunoglobulins Product Market Performance
- 10.1.4 Csl Behring Business Overview
- 10.1.5 Csl Behring Swot Analysis
- 10.1.6 Csl Behring Recent Developments
- 10.2 Grifols
- 10.2.1 Grifols Basic Information
- 10.2.2 Grifols Intravenous Immunoglobulins Product Overview
- 10.2.3 Grifols Intravenous Immunoglobulins Product Market Performance
- 10.2.4 Grifols Business Overview
- 10.2.5 Grifols Swot Analysis
- 10.2.6 Grifols Recent Developments
- 10.3 Octapharma
- 10.3.1 Octapharma Basic Information
- 10.3.2 Octapharma Intravenous Immunoglobulins Product Overview
- 10.3.3 Octapharma Intravenous Immunoglobulins Product Market Performance
- 10.3.4 Octapharma Business Overview
- 10.3.5 Octapharma Swot Analysis
- 10.3.6 Octapharma Recent Developments
- 10.4 Takeda
- 10.4.1 Takeda Basic Information
- 10.4.2 Takeda Intravenous Immunoglobulins Product Overview
- 10.4.3 Takeda Intravenous Immunoglobulins Product Market Performance
- 10.4.4 Takeda Business Overview
- 10.4.5 Takeda Recent Developments
- 10.5 Adma Biologics
- 10.5.1 Adma Biologics Basic Information
- 10.5.2 Adma Biologics Intravenous Immunoglobulins Product Overview
- 10.5.3 Adma Biologics Intravenous Immunoglobulins Product Market Performance
- 10.5.4 Adma Biologics Business Overview
- 10.5.5 Adma Biologics Recent Developments
- 10.6 Bayer
- 10.6.1 Bayer Basic Information
- 10.6.2 Bayer Intravenous Immunoglobulins Product Overview
- 10.6.3 Bayer Intravenous Immunoglobulins Product Market Performance
- 10.6.4 Bayer Business Overview
- 10.6.5 Bayer Recent Developments
- 10.7 Bharat Serum And Vaccines
- 10.7.1 Bharat Serum And Vaccines Basic Information
- 10.7.2 Bharat Serum And Vaccines Intravenous Immunoglobulins Product Overview
- 10.7.3 Bharat Serum And Vaccines Intravenous Immunoglobulins Product Market Performance
- 10.7.4 Bharat Serum And Vaccines Business Overview
- 10.7.5 Bharat Serum And Vaccines Recent Developments
- 10.8 Biotest
- 10.8.1 Biotest Basic Information
- 10.8.2 Biotest Intravenous Immunoglobulins Product Overview
- 10.8.3 Biotest Intravenous Immunoglobulins Product Market Performance
- 10.8.4 Biotest Business Overview
- 10.8.5 Biotest Recent Developments
- 10.9 China Biologic Products
- 10.9.1 China Biologic Products Basic Information
- 10.9.2 China Biologic Products Intravenous Immunoglobulins Product Overview
- 10.9.3 China Biologic Products Intravenous Immunoglobulins Product Market Performance
- 10.9.4 China Biologic Products Business Overview
- 10.9.5 China Biologic Products Recent Developments
- 10.10 Hualan Biological Engineering
- 10.10.1 Hualan Biological Engineering Basic Information
- 10.10.2 Hualan Biological Engineering Intravenous Immunoglobulins Product Overview
- 10.10.3 Hualan Biological Engineering Intravenous Immunoglobulins Product Market Performance
- 10.10.4 Hualan Biological Engineering Business Overview
- 10.10.5 Hualan Biological Engineering Recent Developments
- 10.11 Kedrion Biopharma
- 10.11.1 Kedrion Biopharma Basic Information
- 10.11.2 Kedrion Biopharma Intravenous Immunoglobulins Product Overview
- 10.11.3 Kedrion Biopharma Intravenous Immunoglobulins Product Market Performance
- 10.11.4 Kedrion Biopharma Business Overview
- 10.11.5 Kedrion Biopharma Recent Developments
- 10.12 Lfb Group
- 10.12.1 Lfb Group Basic Information
- 10.12.2 Lfb Group Intravenous Immunoglobulins Product Overview
- 10.12.3 Lfb Group Intravenous Immunoglobulins Product Market Performance
- 10.12.4 Lfb Group Business Overview
- 10.12.5 Lfb Group Recent Developments
- 10.13 Sanquin
- 10.13.1 Sanquin Basic Information
- 10.13.2 Sanquin Intravenous Immunoglobulins Product Overview
- 10.13.3 Sanquin Intravenous Immunoglobulins Product Market Performance
- 10.13.4 Sanquin Business Overview
- 10.13.5 Sanquin Recent Developments
- 11 Intravenous Immunoglobulins Market Forecast By Region
- 11.1 Global Intravenous Immunoglobulins Market Size Forecast
- 11.2 Global Intravenous Immunoglobulins Market Forecast By Region
- 11.2.1 North America Market Size Forecast By Country
- 11.2.2 Europe Intravenous Immunoglobulins Market Size Forecast By Country
- 11.2.3 Asia Pacific Intravenous Immunoglobulins Market Size Forecast By Region
- 11.2.4 South America Intravenous Immunoglobulins Market Size Forecast By Country
- 11.2.5 Middle East And Africa Forecasted Sales Of Intravenous Immunoglobulins By Country
- 12 Forecast Market By Type And By Application (2026-2033)
- 12.1 Global Intravenous Immunoglobulins Market Forecast By Type (2026-2033)
- 12.1.1 Global Forecasted Sales Of Intravenous Immunoglobulins By Type (2026-2033)
- 12.1.2 Global Intravenous Immunoglobulins Market Size Forecast By Type (2026-2033)
- 12.1.3 Global Forecasted Price Of Intravenous Immunoglobulins By Type (2026-2033)
- 12.2 Global Intravenous Immunoglobulins Market Forecast By Application (2026-2033)
- 12.2.1 Global Intravenous Immunoglobulins Sales (K Mt) Forecast By Application
- 12.2.2 Global Intravenous Immunoglobulins Market Size (M Usd) Forecast By Application (2026-2033)
- 13 Conclusion And Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
